Cholesterol-lowering drugs for high-risk hypercholesterolemia patients with COVID-19 while on Paxlovid™ therapy

Paxlovid™ is a promising antiviral oral medication for patients at a high risk of a severe form of COVID-19. Regarding COVID-19 patients who have hypercholesterolemia and are at high or very high risk for an acute atherothrombotic cardiovascular event, we are highlighting patients with heterozygous...

Descripción completa

Detalles Bibliográficos
Autores principales: Vuorio, Alpo, Kovanen, Petri T, Raal, Frederick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2022
Materias:
Special Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345303/
https://www.ncbi.nlm.nih.gov/pubmed/35935448
http://dx.doi.org/10.2217/fvl-2022-0060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345303/
https://www.ncbi.nlm.nih.gov/pubmed/35935448
http://dx.doi.org/10.2217/fvl-2022-0060

Ejemplares similares